{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:41:36Z","timestamp":1793882496033,"version":"4.7.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"medical science and technology project of Henan Province","award":["SBGJ202001002"],"award-info":[{"award-number":["SBGJ202001002"]}]},{"name":"National Health Commission project","award":["CMR-20180615-1001"],"award-info":[{"award-number":["CMR-20180615-1001"]}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"crossref","award":["212102310203"],"award-info":[{"award-number":["212102310203"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-03878-y","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T01:01:58Z","timestamp":1725238918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Umbilical cord mesenchymal stem cells in ulcerative colitis treatment: efficacy and possible mechanisms"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiaoke","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangqiu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-9954","authenticated-orcid":false,"given":"Bingyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"3878_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","volume":"145","author":"KL Glassner","year":"2020","unstructured":"Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. J Allergy Clin Immunol. 2020;145:16\u201327.","journal-title":"J Allergy Clin Immunol"},{"key":"3878_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/ueg2.12317","volume":"10","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Jess T. Implications of the changing epidemiology of inflammatory bowel disease in a changing world. United Eur Gastroenterol J. 2022;10:1113\u201320.","journal-title":"United Eur Gastroenterol J"},{"key":"3878_CR3","doi-asserted-by":"crossref","unstructured":"Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn WJ et al. Natural history of adult ulcerative colitis in population-based cohorts: a systematic review. Clin Gastroenterol Hepatol. 2018;16:343\u2009\u2013\u200956.e3.","DOI":"10.1016\/j.cgh.2017.06.016"},{"key":"3878_CR4","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383:2652\u201364.","journal-title":"N Engl J Med"},{"key":"3878_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S2468-1253(21)00101-1","volume":"6","author":"B Shen","year":"2021","unstructured":"Shen B, Kochhar GS, Kariv R, Ileal Pouch Consortium. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021;6:826\u201349.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3878_CR6","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2147\/JIR.S400447","volume":"16","author":"CM Tian","year":"2023","unstructured":"Tian CM, Zhang Y, Yang MF, Yu M, Chen L, Li H, et al. Stem cell therapy in inflammatory bowel disease: a review of achievements and challenges. J Inflamm Res. 2023;16:2089\u2013119.","journal-title":"J Inflamm Res"},{"key":"3878_CR7","doi-asserted-by":"publisher","first-page":"591065","DOI":"10.3389\/fimmu.2020.591065","volume":"11","author":"S Dabrowska","year":"2020","unstructured":"Dabrowska S, Andrzejewska A, Janowski M, Walczak P, Lukomska B, Drela K, et al. Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases. Front Immunol. 2020;11:591065.","journal-title":"Front Immunol"},{"key":"3878_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.biotechadv.2017.04.005","volume":"35","author":"N Kasoju","year":"2017","unstructured":"Kasoju N, Wang H, Zhang B, Greenaway T, Chan HK, Hu W, et al. Transcriptomics of human multipotent mesenchymal stromal cells: retrospective analysis and future prospects. Biotechnol Adv. 2017;35:407\u201318.","journal-title":"Biotechnol Adv"},{"key":"3878_CR9","doi-asserted-by":"publisher","first-page":"122189","DOI":"10.1016\/j.lfs.2023.122189","volume":"334","author":"Y Fu","year":"2023","unstructured":"Fu Y, Zhang C, Xie H, He H, Zhang Q, Liu J, et al. Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation. Life Sci. 2023;334:122189.","journal-title":"Life Sci"},{"key":"3878_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomized, double-blind controlled trial. Lancet. 2016;388:1281\u201390.","journal-title":"Lancet"},{"key":"3878_CR11","first-page":"749","volume":"138","author":"D Charron","year":"2013","unstructured":"Charron D. Allogenicity & immunogenicity in regenerative stem cell therapy. Indian J Med Res. 2013;138:749\u201354.","journal-title":"Indian J Med Res"},{"key":"3878_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10517-019-04388-1","volume":"166","author":"YA Romanov","year":"2019","unstructured":"Romanov YA, Volgina NE, Vtorushina VV, Romanov AY, Romanov PA, Smirnov VN, et al. Comparative analysis of the secretome of human umbilical cord- and bone marrow-derived multipotent mesenchymal stromal cells. Bull Exp Biol Med. 2019;166:535\u201340.","journal-title":"Bull Exp Biol Med"},{"key":"3878_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3892\/ijmm.2014.1821","volume":"34","author":"X Li","year":"2014","unstructured":"Li X, Bai J, Ji X, Li J, Zhang J, Bai H, et al. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation, and differentiation. Int J Mol Med. 2014;34:695\u2013704.","journal-title":"Int J Mol Med"},{"key":"3878_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/21645515.2015.1030549","volume":"12","author":"Q Wang","year":"2016","unstructured":"Wang Q, Yang Q, Wang Z, He Q, Xu Y, Li H, et al. Comparative analysis of human mesenchymal stem cells from fetal bone marrow, adipose tissue, and Warton\u2019s jelly as sources of cell immunomodulatory therapy. Hum Vaccin Immunother. 2016;12:85\u201396.","journal-title":"Hum Vaccin Immunother"},{"key":"3878_CR15","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462\u201376.","journal-title":"N Engl J Med"},{"key":"3878_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J. 1955;2:1041\u20138.","journal-title":"Br Med J"},{"key":"3878_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF, Rook M, Miller N, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749\u201353.","journal-title":"Gut"},{"key":"3878_CR18","first-page":"63","volume":"128","author":"E Eliadou","year":"2015","unstructured":"Eliadou E, Day AS, Thompson-Fawcett MW, Gearry RB, Bissett IP, Collett JA, et al. New Zealand Society of Gastroenterology Guidelines for the management of Refractory Ulcerative Colitis. N Z Med J. 2015;128:63\u201376.","journal-title":"N Z Med J"},{"key":"3878_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","volume":"145","author":"SP Travis","year":"2013","unstructured":"Travis SP, Schnell D, Krzeski P, Toth GT, D\u2019Haens G, Ding N, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145:987\u201395.","journal-title":"Gastroenterology"},{"key":"3878_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diff.2020.05.005","volume":"114","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lv P, Li Y, Liu Y, Pan L, Song Y, et al. Comparison of the biological characteristics of umbilical cord mesenchymal stem cells derived from the human heterosexual twins. Differentiation. 2020;114:1\u201312.","journal-title":"Differentiation"},{"key":"3878_CR21","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1038\/s41598-018-23396-1","volume":"8","author":"M Wu","year":"2018","unstructured":"Wu M, Zhang R, Zou Q, Hu C, Lu L, Zhu W, et al. Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord. Sci Rep. 2018;8:5014.","journal-title":"Sci Rep"},{"key":"3878_CR22","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jog.13432","volume":"43","author":"FA Dabrowski","year":"2017","unstructured":"Dabrowski FA, Burdzinska A, Kulesza A, Mieczkowski B, Mieczkowska A, Nowosielska D, et al. Comparison of the paracrine activity of mesenchymal stem cells derived from the human umbilical cord, amniotic membrane, and adipose tissue. J Obstet Gynaecol Res. 2017;43:1758\u201368.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"3878_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","volume":"66","author":"A Marchal-Bressenot","year":"2017","unstructured":"Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Calabrese E, et al. Development and validation of the Nancy histological index for UC. Gut. 2017;66(1):43\u20139.","journal-title":"Gut"},{"issue":"5","key":"3878_CR24","first-page":"292","volume":"38","author":"Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association","year":"2018","unstructured":"Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). Zhonghua Xiao Hua Za Zhi. 2018;38(5):292\u2013311.","journal-title":"Zhonghua Xiao Hua Za Zhi"},{"key":"3878_CR25","doi-asserted-by":"publisher","first-page":"e00659","DOI":"10.1128\/MCB.00659-16","volume":"37","author":"K Wheaton","year":"2017","unstructured":"Wheaton K, Campuzano D, Ma W, Sheinis M, Ho B, Brown GW, et al. Progerin-induced replication stress facilitates premature senescence in Hutchinson-Gilford progeria syndrome. Mol Cell Biol. 2017;37:e00659\u201316.","journal-title":"Mol Cell Biol"},{"key":"3878_CR26","doi-asserted-by":"publisher","first-page":"952071","DOI":"10.3389\/fimmu.2022.952071","volume":"13","author":"Z Che","year":"2022","unstructured":"Che Z, Ye Z, Zhang X, Ma Z, Yan Y, Yu D, et al. Mesenchymal stem\/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases. Front Immunol. 2022;13:952071.","journal-title":"Front Immunol"},{"key":"3878_CR27","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.3390\/ijms23168905","volume":"23","author":"N Eiro","year":"2022","unstructured":"Eiro N, Fraile M, Gonz\u00e1lez-Jubete A, Costa L, Monteiro J, Veiga F, et al. Mesenchymal (stem) stromal cells based as a new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and challenges. Int J Mol Sci. 2022;23:8905.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3878_CR28","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.3390\/jcm9123922","volume":"9","author":"SK Hosseini-Asl","year":"2020","unstructured":"Hosseini-Asl SK, Mehrabani D, Karimi-Busheri F. Therapeutic effect of mesenchymal stem cells in Ulcerative Colitis: A Review on achievements and challenges. J Clin Med. 2020;9(12):3922.","journal-title":"J Clin Med"},{"key":"3878_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","volume":"369","author":"BG Feagan","year":"2013","unstructured":"Feagan BG, Rutgeerts P, Sands BE, Hanauer SB, Colombel JF, Sandborn WJ, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369:699\u2013710.","journal-title":"N Engl J Med"},{"key":"3878_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcyt.2015.10.011","volume":"18","author":"M Najar","year":"2016","unstructured":"Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L, et al. Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells. Cytotherapy. 2016;18:160\u201371.","journal-title":"Cytotherapy"},{"key":"3878_CR31","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53:e12712.","journal-title":"Cell Prolif"},{"key":"3878_CR32","first-page":"e28981","volume":"14","author":"S Ali","year":"2022","unstructured":"Ali S, Paul S, Yakkali S, Hussain S, Khan S, Shaik S, et al. Glucocorticoids-induced neuropsychiatric disorders in patients with inflammatory bowel disease: a systematic review. Cureus. 2022;14:e28981.","journal-title":"Cureus"},{"key":"3878_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11894-021-00829-y","volume":"23","author":"L Sattler","year":"2021","unstructured":"Sattler L, Hanauer SB, Malter L. Immunomodulatory agents for the treatment of patients with inflammatory bowel disease (review the safety of anti-TNF, anti-integrin, anti IL-12\/23, JAK inhibition, sphingosine 1-phosphate receptor modulator, azathioprine \/ 6-MP, and methotrexate). Curr Gastroenterol Rep. 2021;23:30.","journal-title":"Curr Gastroenterol Rep"},{"key":"3878_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ibd\/izab039","volume":"28","author":"AS Faye","year":"2022","unstructured":"Faye AS, Colombel JF. Aging and IBD: a new challenge for clinicians and researchers. Inflamm Bowel Dis. 2022;28:126\u201332.","journal-title":"Inflamm Bowel Dis"},{"key":"3878_CR35","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1007\/s11427-022-2161-3","volume":"65","author":"Y Cai","year":"2022","unstructured":"Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, et al. The landscape of aging. Sci China Life Sci. 2022;65:2354\u2013454.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"3878_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.23736\/S2724-5985.21.02934-X","volume":"70","author":"MC Fantini","year":"2021","unstructured":"Fantini MC, Onali S, Gasbarrini A, Lopetuso LR. Immune system and gut microbiota senescence in elderly patients with IBD. Minerva Gastroenterol (Torino). 2021;70(1):59\u201367. https:\/\/doi.org\/10.23736\/S2724-5985.21.02934-X.","journal-title":"Minerva Gastroenterol (Torino)"},{"issue":"1","key":"3878_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41392-021-00765-3","volume":"6","author":"X Xiao","year":"2021","unstructured":"Xiao X, Xu M, Yu H, Wang L, Li X, Rak J, Wang S, Zhao RC. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a\/Src. Signal Transduct Target Ther. 2021;6(1):354.","journal-title":"Signal Transduct Target Ther"},{"key":"3878_CR38","unstructured":"Lazebnik LB, Kniazev OV, Parfenov AI, Konopliannikov AG, Sagynbaeva V\u00c9, Ruchkina IN, Efremov LI, Shcherbakov PL. Age as a prognostic factor in the treatment effectiveness of patients with ulcerative colitis with help of mesenchymal stromal cells. Eksp Klin Gastroenterol. 2010;(12):3\u20139. Russian."},{"key":"3878_CR39","doi-asserted-by":"publisher","first-page":"1029948","DOI":"10.3389\/fimmu.2022.1029948","volume":"13","author":"H Zheng","year":"2022","unstructured":"Zheng H, Zhang C, Wang Q, Feng S, Fang Y, Zhang S. The impact of aging on intestinal mucosal immune function and clinical applications. Front Immunol. 2022;13:1029948.","journal-title":"Front Immunol"},{"issue":"9","key":"3878_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41575-022-00605-x","volume":"19","author":"TS Ghosh","year":"2022","unstructured":"Ghosh TS, Shanahan F, O\u2019Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol. 2022;19(9):565\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3878_CR41","doi-asserted-by":"publisher","first-page":"1055914","DOI":"10.3389\/fimmu.2022.1055914","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Ruan G, Cheng Y, Yi A, Chen D, Wei Y. The role of Th17 cells in inflammatory bowel disease and the research progress. Front Immunol. 2023;13:1055914.","journal-title":"Front Immunol"},{"key":"3878_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417\u201326.","journal-title":"Mol Cell"},{"key":"3878_CR43","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1097\/MIB.0b013e3182a563cb","volume":"19","author":"L Ohman","year":"2013","unstructured":"Ohman L, Dahl\u00e9n R, Isaksson S, Sjoling A, Wick MJ, Sjovall H, et al. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease. Inflamm Bowel Dis. 2013;19:2433\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"3878_CR44","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/MIB.0b013e318286fa1c","volume":"19","author":"EGW Schmidt","year":"2013","unstructured":"Schmidt EGW, Larsen HL, Kristensen NN, Poulsen SS, Pederson AML, Claesson MH, et al. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis. Inflamm Bowel Dis. 2013;19:1567\u201376.","journal-title":"Inflamm Bowel Dis"},{"key":"3878_CR45","doi-asserted-by":"publisher","first-page":"e23532","DOI":"10.1002\/jbt.23532","volume":"38","author":"S Ali Mohammed","year":"2024","unstructured":"Ali Mohammed S, Elbaramawy A, Abd-Allah SH, Elkholy A, Elsayed NI, Hussein S. Therapeutic potentials of mesenchymal stem cells in treating inflammatory bowel disease in rats. J Biochem Mol Toxicol. 2024;38:e23532.","journal-title":"J Biochem Mol Toxicol"},{"key":"3878_CR46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1215739","volume":"369","author":"WJ Sandborn","year":"2013","unstructured":"Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, et al. Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med. 2013;369:711\u201321.","journal-title":"N Engl J Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03878-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03878-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03878-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T13:19:17Z","timestamp":1725283157000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03878-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3878"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03878-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"12 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was authorized by the Ethics Committee of Henan Provincial People\u2019s Hospital (project title: Clinical study of mesenchymal stem cells in the treatment of moderately refractory ulcerative colitis; Approval number: (2018) NO.03\u2009\u2212\u200901; date of approval: 25 January 2018). All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}